Clinical Research Division


Below is a selection of papers faculty and staff from Clinical Biostatistics have participated on.

1. Gooley TA, Leisenring W, Crowley J, Storer BE:  Estimation of failure probabilities in the presence of competing risks:  New representations of old estimators.  Statistics in Medicine 18: 695-706, 1999.

2.  Gooley T, Rajvanshi P, Schoch HJ, McDonald GB:  Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation.  Hepatology 41: 345-352, 2005.

3.   Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB: Reduced mortality after allogeneic hematopoietic cell transplantation.  N Engl J Med 363(22): 2158-9, 2010. PMCID: PMC3017343

4.   Petersdorf EW, Malkki M, O'hUigin C, Carrington M, Gooley T, Haagenson MD, Horowitz MM, Spellman SR, Wang T, Stevenson P: High HLA-DP Expression and Graft-versus-Host Disease. N Engl J Med. 373(7):599-609, 2015. PMCID: PMC4560117 [Available on 2016-02-13]

5.   Leisenring WM, Mertens AC, Armstrong GT, Stovall MA, Neglia JP, Lanctot JQ, Boice Jr. JD, Whitton JA, Yasui Y: Pediatric Cancer Survivorship Research: experience of the Childhood Cancer Survivor Study. Journal of Clinical Oncology 27: 2319-27, 2009. PMCID: PMC2738644

6.   Leisenring W, Pepe M:  Regression modelling of diagnostic likelihood ratios for the evaluation of medical diagnostic tests.  Biometrics 54:444-452, 1998.

7.   Phillips SM, Padgett LS, Leisenring WM, Stratton KK, Bishop K, Krull KR, Alfano CM, Gibson TM, de Moor JS, Hartigan DB, Armstrong GT, Robison LL, Rowland JH, Oeffinger KC, Mariotto AB: Survivors of Childhood Cancer in the United States: Prevalence and Burden of Morbidity. Cancer Epidemiology, Biomarkers & Prevention 2015. PMCID: PMC4418452

8.   Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers MED, Stevens-Ayers T, Jerome KR, Leisenring W: A Phase III Multicenter Randomized Double Blind Trial of Valganciclovir for the Prevention of Complications of Late Cytomegalovirus Infection after Allogeneic Hematopoietic Cell Transplantation. Annals of Internal Medicine 162(1): 1-10, 2015. PMCID: PMC4465336 [Available on 2016-01-06]

9.   Zerr DM, Fann JR, Breiger D, Boeckh M, Adler Al, Xie H, Delaney C, Huang M-L, Corey L, Leisenring WM: HHV-6 Reactivation and its Effect on Delirium and Cognitive Functioning in Hematopoietic Cell Transplant Recipients. Blood 117: 5243-9, 2011. PMCID: PMC3109545.

10.  Redman MW, Crowley JJ., Herbst RS, Hirsch FR, Gandara, DR: Design of a phase III clinical trial with prospective biomarker validation: SWOG S0819. Clin Cancer Res. 2012 Aug 1;18(15):4004-12. Epub 2012 May 16. PMCID: PMC3409929

11.  Redman MW, Tangen CM, Goodman PJ, Lucia MS, Coltman CA, Jr, Thompson IM: Finasteride does not increase the risk of high-grade prostate cancer:  a bias-adjusted modeling approach. Cancer Prev Res 1(3):174-181, 2008. PMCID: PMC2844801

12.  Storer BE:  Design and analysis of phase I clinical trials.  Biometrics 45:925-937, 1989. PMID 2790129

13.   Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, Storer B:  Hematopoietic cell transplantation (HCT)-specific comorbidity index:  a new tool for risk assessment before allogeneic HCT.  Blood 106:2912-2919, 2005. PMCID: PMC1895304

14.  Storer BE, Gooley TA, Jones MP: Adjusted estimates for time-to-event endpoints.  Lifetime Data Analysis 14:484-495, 2008. PMCID: PMC2660858

15.  Martin PJ, Counts GW, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, Flowers ME, Syrjala KL, Hansen JA, Storb RF, Storer BE: Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.  Journal of Clinical Oncology 28: 1011-1016, 2010. PMCID: PMC2834427